ThePrint on MSN18h
How Chinese biotech firm BGI grew to rival US giant Illumina & enter US-China tariff warChina has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...
Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief ...
Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...
The provision will enable whole genome sequencing for neonatal and paediatric patients in intensive care units within 48 ...
Illumina, Inc. (NASDAQ:ILMN – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Wednesday after Morgan Stanley lowered their price target on the stock from $150.00 to ...
News Medical on MSN20h
Leveling up NGS workflows with INTEGRA Biosciences’ solutionsINTEGRA Biosciences offers liquid handling solutions and magnetic modules to streamline every stage of NGS sample preparation ...
Researchers have created a novel imaging-technology combination that can capture gene activity in individual bacteria in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback